Large International Validation of ABSIS and PDAI Pemphigus Severity Scores.

Hebert, Vivien; Boulard, Claire; Houivet, Estelle; Duvert Lehembre, Sophie; Borradori, Luca; Della Torre, Rocco Carlo Riccardo; Feliciani, Claudio; Fania, Luca; Zambruno, Giovanna; Camaioni, Diana B; Didona, Biago; Marinovic, Branka; Schmidt, Enno; Schumacher, Nina; Hünefeld, Christian; Schanz, Stefan; Kern, Johannes Steffen; Hofmann, Silke; Bouyeure, Anne Charlotte; Picard-Dahan, Catherine; ... (2019). Large International Validation of ABSIS and PDAI Pemphigus Severity Scores. Journal of investigative dermatology, 139(1), pp. 31-37. Elsevier 10.1016/j.jid.2018.04.042

[img] Text
Large International.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (575kB) | Request a copy

The Pemphigus Disease Area Index (PDAI) and Autoimmune Bullous Skin Disorder Intensity-Score (ABSIS) scores have been proposed to provide an objective measure of pemphigus activity. These scores have been evaluated only on already treated patients mainly with mild to moderate activity. The objective was to assess the interrater reliability of ABSIS and PDAI scores and their correlation with other severity markers in a large international study. Consecutive patients with newly diagnosed pemphigus were enrolled in 31 centers. Severity scores were recorded during a 24-month period by the same two blinded investigators. Serum was collected at each visit for ELISA measurement of anti-desmoglein antibodies. The intraclass correlation coefficient (ICC) and Spearman rank correlation coefficient were calculated. A total of 116 patients with pemphigus vulgaris (n = 84) or pemphigus foliaceus (n = 32) were included. At baseline, the ABSIS and PDAI ICCs were 0.90 (95% confidence interval [CI] = 0.85-0.93), and 0.91(95% CI = 0.87-0.94), respectively. The ICCs for PDAI were higher in moderate and extensive pemphigus (ICC = 0.82, 95% CI = 0.63-0.92 and ICC = 0.80, 95% CI = 0.62-0.90, respectively) than in patients with intermediate (significant) extent (ICC = 0.50, 95% CI = 0.27-0.68). Conversely, the ICCs for ABSIS were lower in patients with moderate extent (ICC = 0.44, 95% CI = 0.004-0.74) than in those with intermediate or extensive forms, (ICC = 0.69, 95% CI = 0.51-0.81 and ICC = 0.75, 95% CI = 0.51-0.88, respectively). During patients' follow-up, the ICCs of both ABSIS and PDAI scores remained higher than 0.70. ABSIS and PDAI skin (r = 0.71 and r = 0.75) but not mucosal (r = 0.32 and r = 0.37) subscores were correlated with the evolution of anti-DSG1 and anti-DSG3 ELISA values, respectively. ABSIS and PDAI scores are robust tools to accurately assess pemphigus activity.

Item Type:

Journal Article (Review Article)

Division/Institute:

04 Faculty of Medicine > Department of Dermatology, Urology, Rheumatology, Nephrology, Osteoporosis (DURN) > Clinic of Dermatology

UniBE Contributor:

Borradori, Luca and Della Torre, Rocco Carlo Riccardo

Subjects:

600 Technology > 610 Medicine & health

ISSN:

0022-202X

Publisher:

Elsevier

Language:

English

Submitter:

Sandra Nyffenegger

Date Deposited:

30 Nov 2018 08:59

Last Modified:

25 Dec 2018 01:32

Publisher DOI:

10.1016/j.jid.2018.04.042

PubMed ID:

30301637

BORIS DOI:

10.7892/boris.121865

URI:

https://boris.unibe.ch/id/eprint/121865

Actions (login required)

Edit item Edit item
Provide Feedback